That’s a quick turnaround from the recent quarterly:
2. Submission EU Common List Registration - The clinical trial in Europe is ongoing. AnteoTech remains on track for the European Common List registration submission in Q2 FY2023.
Hopefully nobody invested after reading that the EU common List Application was to be submitted imminently.
The question is, was this the decision of an incoming CEO making quick decisions to save the company, or again was this a car crash in the making, being that the outlier information has been kept quiet.
At least someone made a quick decision for once.
- Forums
- ASX - By Stock
- ADO
- Ann: European RAT Clinical Trial Halted to Refocus Initiatives
Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-22
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.001(5.00%) |
Mkt cap ! $51.84M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 1.9¢ | $24.34K | 1.215M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 1080621 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 0.020 |
4 | 1580000 | 0.019 |
16 | 1271612 | 0.018 |
5 | 807891 | 0.017 |
5 | 1728529 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 1080621 | 4 |
0.022 | 255000 | 2 |
0.024 | 531781 | 3 |
0.025 | 406936 | 5 |
0.026 | 45454 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |